hat
Ibrutinib (Imbruvica) se yon ti dwòg molekil ki mare toutan nan yon pwoteyin, briton a tyrosine kinase (BTK), ki enpòtan nan selil B; se dwòg la itilize trete kansè selil tankou lymphom selil manto, lesemi lenfositik kwonik, ak macroglobulinemia Waldenström a, yon fòm ki pa Lymphoma Hodgkin a.
eng
Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia, a form of non-Hodgkin's lymphoma.